Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 722 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosis

Yassin Mohamed A, Soliman Ashraf T, De Sanctis Vincenzo, Abdelrahman Mohamed Osman, Aziz Bedair Elsaid M, AbdelGawad Manal

Year : 2014| Volume: 18| Issue : 4 | Page no: 546-551

   This article has been cited by
1 Rheumatic Manifestations of Haemoglobinopathies
Michael Hughes
Current Rheumatology Reports. 2018; 20(10)
[Pubmed]  [Google Scholar] [DOI]
2 Denosumab for the treatment of osteoporosis
Michael R. McClung
Osteoporosis and Sarcopenia. 2017;
[Pubmed]  [Google Scholar] [DOI]
3 Clinical Complications and Their Management
Alessia Marcon,Irene Motta,Ali Taher,Maria Domenica Cappellini
Hematology/Oncology Clinics of North America. 2017;
[Pubmed]  [Google Scholar] [DOI]
4 Bone disease in thalassemia patients: past, present and future perspectives
Vincenzo De Sanctis,Ashraf T. Soliman,Heba Elsefdy,Nada Soliman,Elsaid Bedair,Bernadette Fiscina,Christos Kattamis
Metabolism. 2017;
[Pubmed]  [Google Scholar] [DOI]
5 Management of beta-thalassemia-associated osteoporosis
Andrea Giusti,Valeria Pinto,Gian Luca Forni,Alberto Pilotto
Annals of the New York Academy of Sciences. 2016;
[Pubmed]  [Google Scholar] [DOI]
6 Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease
A. D. Dede,G. Trovas,E. Chronopoulos,I. K. Triantafyllopoulos,I. Dontas,N. Papaioannou,S. Tournis
Osteoporosis International. 2016;
[Pubmed]  [Google Scholar] [DOI]
7 Denosumab for the treatment of osteoporosis
Sarah Zaheer,Meryl LeBoff,E Michael Lewiecki
Expert Opinion on Drug Metabolism & Toxicology. 2015; : 1
[Pubmed]  [Google Scholar] [DOI]
8 A complicated disease: what can be done to manage thalassemia major more effectively?
Raffaella Origa,Alessandro Baldan,Maria Marsella,Caterina Borgna-Pignatti
Expert Review of Hematology. 2015; 8(6): 851
[Pubmed]  [Google Scholar] [DOI]


Read this article